PRRT is a possible treatment for some NETs that start in the pancreas or the digestive system. It is not a treatment for NECs. Radioisotope therapy uses radioactive medicines to treat some cancer ...

She noted the survival benefit with the combination was achieved even though 38% of patients in the enzalutamide-alone arm ...

This study utilizes bibliometric analysis to investigate the research landscape of FAP-directed cancer theranostics, focusing ...

Vivos continues to collaborate with its contract manufacturer, IsoTherapeutics, recently acquired by Telix (Nasdaq: TLX), to enhance production capacity for both Isopet ™ and RadioGel ®.